Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery.
Sciarra A, et al. -Urol Oncol. 2013 Jul;31(5):607-14.
Abstract presented and comments included by Dr. Israel Barken, the medical director of the Prostate Cancer Research and Education Foundation. Please visit our web site http://www.pcref.org